Nate is responsible for developing purification methods to support preclinical and clinical development. He spent eight years at Pfizer in process development to support small molecule and vaccine therapeutic clinical trials and post-launch manufacturing. He then transitioned into an academic position at North Carolina Central University in its Department of Chemistry and Biochemistry. At NCCU, he taught Organic Chemistry and Biochemistry courses as well as performed protein engineering research. After seven years at NCCU, he transitioned back into industry.
Nate earned a BS in Chemistry from Purdue University and a PhD in Chemistry from Duke University.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
